MVP 2.04% 48.0¢ medical developments international limited

Ann: Investor Presentation - $30m Capital Raise and FY22 Guidance, page-17

  1. 507 Posts.
    lightbulb Created with Sketch. 70
    Penthrox is not an alternative to addictive opoids. You are very wrong comparing acute presentations to long term chronic pain.
    Penthrox has no use in chronic pain. Yes the current long term addictive pain killers need alternatives like norspan and cannibis flower, oil which has taken the market by storm.
    Penthrox is a very small market for acute surgeries and accidents that's it.
    A stat dose of morphine compared to penthrox is the problem both will get you to icu but 1 is 100x more expensive.
    I like intelligent investor but as a user of penthox the applications are seriously limited to acute care.


    Last edited by Neverlookback: 11/08/22
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
(20min delay)
Last
48.0¢
Change
-0.010(2.04%)
Mkt cap ! $41.85M
Open High Low Value Volume
49.5¢ 49.5¢ 47.5¢ $1.633K 3.351K

Buyers (Bids)

No. Vol. Price($)
1 990 48.0¢
 

Sellers (Offers)

Price($) Vol. No.
49.0¢ 21 1
View Market Depth
Last trade - 11.03am 24/07/2024 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.